Company

XenoPort Inc.

XenoPort develops biopharmaceutical treatments for neurological diseases.

About

XenoPort develops medicines for neurological conditions and uses drug delivery technologies in its therapeutic development. Founded in 1999, the company was based in Santa Clara, US. It raised USD 20.00 mn in a PIPE round in June 2005 and is publicly traded.

6Funding rounds

16Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in